Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.
Atalar B, et al.
Radiother Oncol. 2018 Apr;127(1):96-102. doi: 10.1016/j.radonc.2017.12.028. Epub 2018 Jan 17.
Radiother Oncol. 2018.
PMID: 29373196